Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

[Use of human anti-Pseudomonas immunoglobulins in treatment of children with burns].

Bukowska D, Wegrzynowicz Z, Rudowski W, Kraj M, Rosiek A, Gardzińska E, Popiel D.

Pol Tyg Lek. 1996 Jun;51(23-26):331-3. Polish.

PMID:
9273523
2.

Cryoprecipitate of intermediate purity produced in a closed thaw-siphon system from DDAVP stimulated blood donor plasma.

Konecka G, Bykowska K, Ludwicka A, Letowska M, Wegrzynowicz Z, Sablinski J, Lopaciuk S.

Folia Haematol Int Mag Klin Morphol Blutforsch. 1990;117(4):565-70.

PMID:
1714861
3.

A new chromogenic assay for direct detection of staphylocoagulase.

Bulanda M, Wegrzynowicz Z, Ciurak M, Kowalczyk J, Kupryszewski G, Gruszka M, Heczko PB, Pulverer G.

Zentralbl Bakteriol Mikrobiol Hyg A. 1988 Nov;270(1-2):115-21.

PMID:
3223133
4.

Plasma fibronectin in acute leukaemias and during streptokinase therapy.

Bykowska K, Janczarski M, Wegrzynowicz Z, Lopaciuk S, Kopeć M.

Mater Med Pol. 1988 Apr-Jun;20(2):114-8. No abstract available.

PMID:
3221728
5.

Anticoagulant properties of extracellular slime substance produced by Staphylococcus epidermidis.

Bykowska K, Ludwicka A, Wegrzynowicz Z, Lopaciuk S, Kopeć M.

Thromb Haemost. 1985 Dec 17;54(4):853-6.

PMID:
4089818
6.
7.

Plasma fibronectin concentrations in healthy and septic infants.

Domula M, Bykowska K, Wegrzynowicz Z, Lopaciuk S, Weissbach G, Kopéc M.

Eur J Pediatr. 1985 May;144(1):49-52.

PMID:
3894029
8.

Prothrombin activation by a metalloprotease from Staphylococcus aureus.

Wegrzynowicz Z, Heczko PB, Drapeau GR, Jeljaszewicz J, Pulverer G.

J Clin Microbiol. 1980 Aug;12(2):138-9.

9.

INfluence of Pseudomonas aeruginosa proteases on prothrombin, plasminogen and fibrinogen.

Pulverer G, Wegrzynowicz Z, Ko HL, Jeljaszewicz J.

Zentralbl Bakteriol A. 1980;248(1):99-109.

PMID:
6781167
10.

Separation of fibrinogen degradation products (FDP) by means of adsorption to insolubilized fibrinmonomer (FM-ag).

Heene DL, Matthias FR, Wegrzynowicz Z, Hocke G.

Thromb Haemost. 1979 Jun 30;41(4):677-86.

PMID:
483241
11.

Pseudocoagulase activity of staphylococci.

Wegrzynowicz Z, Heczko PB, Jeljaszewicz J, Neugebauer M, Pulverer G.

J Clin Microbiol. 1979 Jan;9(1):15-9.

12.

The nature of clotting and fibrinolytic activities of Bacteroids melaninogenicus.

Wegrzynowicz Z, Ko HJ, Pulverer G, Jeljaszewicz J.

Zentralbl Bakteriol Orig A. 1978 Jan;240(1):106-11.

PMID:
24965
13.

Clotting and fibrinolytic activities of Bacteroides melaninogenicus.

Pulverer G, Ko HL, Wegrzynowicz Z, Jeljaszewicz J.

Zentralbl Bakteriol Orig A. 1977 Dec;239(4):510-3.

PMID:
24963
14.

[Staphylocoagulase and staphylothrombin].

Zajdel M, Wegrzynowicz Z, Sawecka J, Jeljaszewicz J.

Postepy Hig Med Dosw. 1977 Jan-Feb;31(1):17-31. Review. Polish. No abstract available.

PMID:
325544
15.

Studies on chemically modified fibrinogen. II. Physicochemical properties of maleylated fibrinogen.

Kloczewiak M, Wegrzynowicz Z, Matthias FR, Heene DL.

Thromb Res. 1976 Oct;9(4):359-68. No abstract available.

PMID:
982356
16.

Studies on chemically modified fibrinogen.

Kloczewiak M, Wegrzynowicz Z, Matthias FR, Heene DL, Zajdel M.

Thromb Haemost. 1976 Apr 30;35(2):324-33.

PMID:
989632
17.

Bovine fibrinogen modified with 3H-acetic anhydride (3H-AcOAc).

Wegrzynowicz Z, Kloczewiak M, Kopec M.

J Lab Clin Med. 1975 Aug;86(2):360-8.

PMID:
239078
18.

Subunits and susceptibility of fibrins formed from bovine fibrinogen by arvin, reptilase, thrombin and staphylothrombin.

Zajdel M, Wegrzynowicz Z, Sawecka J, Kopeć M.

Thromb Res. 1975 Apr;6(4):337-44. No abstract available.

PMID:
1169826
19.

Effects of histones and dextran on some properties of fibrin, particularly on its susceptibility to plasmin.

Kppeć M, Wegrzynowicz Z, Zajdel M, Sawecka J, Szumiel I.

Thromb Res. 1974 Sep;5(3):359-74. No abstract available.

PMID:
4280155
20.

Reduction of insolubilized fibrinogen.

Matthias FR, Heene DL, Wegrzynowicz Z.

Thromb Res. 1974 Jun;4(6):803-8. No abstract available.

PMID:
4844062
21.

Release of thrombogenic factors by X rays.

Wegrzynowicz Z, Wronowski T, Latallo ZS, Kopeć M.

Arch Immunol Ther Exp (Warsz). 1974;22(5):689-94. No abstract available.

PMID:
4447452
22.

[Structure and function of fibrinogen (fbg) and its degradation products (FDP)].

Latallo ZS, Wegrzynowicz Z, Dudek G, Kloczewiak M, Kopeć M.

Folia Med Cracov. 1974;16(1):140-1. Polish. No abstract available.

PMID:
4275635
23.

Mechanism of action of staphylocoagulase and clumping factor.

Zajdel M, Wegrzynowicz Z, Jeljaszewicz J, Pulverer G.

Contrib Microbiol Immunol. 1973;1:364-75. No abstract available.

PMID:
4805312
24.

Effects of x-rays irradiation on collagen-platelet interaction.

Kopec M, Jeleńska M, Wegrzynowicz Z, Dancewicz AM.

Acta Univ Carol Med Monogr. 1972;53:41-4. No abstract available.

PMID:
4677608
25.

Mutual interaction between platelets and fibrinogen and its derivatives.

Stachurska J, Wegrzynowicz Z, Latallo ZS, Kopec M.

Acta Univ Carol Med Monogr. 1972;53:17-20. Review. No abstract available.

PMID:
4275439
26.

Antithrombin action of fibrinogen degradation products (FDP).

Kopeć M, Wegrzynowicz Z, Kloczewiak M, Latallo ZS.

Folia Haematol Int Mag Klin Morphol Blutforsch. 1972;98(4):417-25. No abstract available.

PMID:
4121335
27.

[A simple method for the determination of intravascular clotting and fibrinolysis].

Latallo ZS, Wegrzynowicz Z, Kopeć M.

Folia Haematol Int Mag Klin Morphol Blutforsch. 1972;97(1):32-5. German. No abstract available.

PMID:
4114580
28.

[Fibrinoplastic properties of cell components and antagonistic action of acid mucipolysaccharides].

Wegrzynowicz Z, Latallo ZS, Kopeć M.

Acta Haematol Pol. 1971 Oct-Dec;2(4):297-304. Polish. No abstract available.

PMID:
4267288
29.

[Detection of states of intravascular activation of blood clotting. I. Results of paracoagulation reaction in the course of various diseases].

Palester-Chlebowczyk M, Strzyzewska E, Wegrzynowicz Z, Latallo Z.

Pol Arch Med Wewn. 1971;46(3):323-32. Polish. No abstract available.

PMID:
5552269
30.

Formation of soluble fibrin complexes and some factors affecting their solubility.

Wegrzynowicz Z, Kopeć M, Latallo ZS.

Scand J Haematol Suppl. 1971;13:49-59. No abstract available.

PMID:
5290703
31.

Simple and rapid evaluation of the intravascular coagulation and fibrinolytic states by application of protamine sulphate and reptilase R.

Latallo ZS, Wegrzynowicz Z, Teisseyre E, Kopeć M.

Scand J Haematol Suppl. 1971;13:387-8. No abstract available.

PMID:
5290699
32.

Preparation of soluble fibrin complexes in plasma.

Latallo ZS, Wegrzynowicz Z, Kopeć M.

Scand J Haematol Suppl. 1971;13:385. No abstract available.

PMID:
5290698
33.

Preliminary results of the protamine sulphate test in plasma of various patients.

Palester-Chlebowczyk M, Strzyzewska E, Sitkowski W, Olender A, Wegrzynowicz Z, Latallo ZS.

Scand J Haematol Suppl. 1971;13:183-8. No abstract available.

PMID:
5290679
34.

Effect of protamine sulphate on the solubility of fibrinogen, its derivatives and other plasma proteins.

Latallo ZS, Wegrzynowicz Z, Budzyński AZ, Kopeć M.

Scand J Haematol Suppl. 1971;13:151-62. No abstract available.

PMID:
5290676
35.

Degradation of fibrinogen by proteolytic enzymes.

Latallo ZS, Teisseyre E, Wegrzynowicz Z, Kopéc M.

Scand J Haematol Suppl. 1971;13:15-9. No abstract available.

PMID:
4258200
36.

Effect of various proteolytic enzymes on fibrinogen.

Latallo ZS, Teisseyre E, Wegrzynowicz Z, Kopec M.

Folia Haematol Int Mag Klin Morphol Blutforsch. 1971;95(2):158-66. No abstract available.

PMID:
4106004
37.

Precipitation of soluble fibrin monomer complexes SFMC by cellular basic proteins, and the antagonistic effect of sulfonated mycopolysaccharides.

Kopec M, Wegrzynowicz Z, Latallo ZS.

Proc Soc Exp Biol Med. 1970 Dec;135(3):675-9. No abstract available.

PMID:
5486701
38.

The effect of proteolytic enzymes on fibrin stabilizing factor.

Kopeć M, Latallo ZS, Stahl M, Wegrzynowicz Z.

Biochim Biophys Acta. 1969 Jul 1;181(2):437-45. No abstract available.

PMID:
4239917
39.

Standardized procedure for determination of staphylocoagulase.

Wegrzynowicz Z, Jeljaszewicz J, Lipinski B.

Appl Microbiol. 1969 Apr;17(4):556-8.

40.

[Fibrinogen synthesis in blood platelets].

Rosiek O, Wegrzynowicz Z, Sawicki Z, Kopec M.

Folia Haematol Int Mag Klin Morphol Blutforsch. 1969;92(4):553-7. German. No abstract available.

PMID:
4193176
41.

[Further results of studies on metabolic disorders in a population of severely retarded children (2)].

Opałka S, Galewicz A, Pisarska E, Wegrzynowicz Z.

Psychiatr Neurol Med Psychol Beih. 1968;8-9:126-9. German.

PMID:
5006367
42.

Formation and properties of fibrin clots resulting from staphylocoagulase (SC) action.

Kopeć M, Wegrzynowicz Z, Budzyński AZ, Jeljaszewicz J, Latallo ZS, Lipiński B, Kowalski E.

Thromb Diath Haemorrh. 1967 Dec 31;18(3-4):475-86. No abstract available.

PMID:
5590240
43.

High molecular weight products of the late stage of fibrinogen proteolysis by plasmin and their structural relation to the fibrinogen molecule.

Budzyński AZ, Stahl M, Kopeć M, Latallo ZS, Wegrzynowicz Z, Kowalski E.

Biochim Biophys Acta. 1967 Oct 23;147(2):313-23. No abstract available.

PMID:
4229214
44.

Soluble unclottable complexes formed in the presence of fibrinogen degradation products (FDP) during the fibrinogen-fibrin conversion and their potential significance in pathology.

Lipinski B, Wegrzynowicz Z, Budzynski AZ, Kopeć M, Latallo ZS, Kowalski E.

Thromb Diath Haemorrh. 1967 Feb 28;17(1-2):65-77. No abstract available.

PMID:
5584961
45.

A lysosomal concept of the platelet release reaction and viscous metamorphosis.

Kowalski E, Kopeć M, Wegrzynowicz Z, Hurwic M, Budzyński AZ.

Thromb Diath Haemorrh. 1966 Jul 31;16(1):134-52. No abstract available.

PMID:
4229623
46.

Studies on the mechanism of interference by fibrinogen degradation products (FDP) with the platelet function role of fibrinogen in the platelet atmosphere.

Kopéc M, Budzyński A, Stachurska J, Wegrzynowicz Z, Kowalski E.

Thromb Diath Haemorrh. 1966 May 15;15(3):476-90. No abstract available.

PMID:
5989032
47.

CIRCULATING FIBRINOGEN DEGRADATION PRODUCTS (FDP) IN DOG BLOOD AFTER INTRAVENOUS THROMBIN INFUSION.

KOWALSKI E, BUDZYNSKI AZ, KOPEC M, LATALLO ZS, LIPINSKI B, WEGRZYNOWICZ Z.

Thromb Diath Haemorrh. 1965 Mar 15;13:12-24. No abstract available.

PMID:
14285962
48.

[FIBRINOGEN CLEAVAGE PRODUCTS AND HEMOSTASIS].

KOWALSKI E, BUDZYNSKI Z, KOPEC M, LATALLO ZS, LIPINSKI B, WEGRZYNOWICZ Z.

Z Gesamte Inn Med. 1965 Mar 1;20:SUPPL:296-300. German. No abstract available.

PMID:
14306479
49.

STUDIES ON THE MOLECULAR PATHOLOGY AND PATHOGENESIS OF BLEEDING IN SEVERE FIBRINOLYTIC STATES IN DOGS.

KOWALSKI E, BUDZYNSKI AZ, KOPEC M, LATALLO ZS, LIPINSKI B, WEGRZYNOWICZ Z.

Thromb Diath Haemorrh. 1964 Oct 15;12:69-86. No abstract available.

PMID:
14224647
50.

STUDIES ON THE COAGULATION AND FIBRINOLYTIC SYSTEM IN LETHALLY IRRADIATED DOGS.

WEGRZYNOWICZ Z, KOPEC M, LATALLO Z, KOWALSKI E.

Arch Immunol Ther Exp (Warsz). 1964;12:524-33. No abstract available.

PMID:
14252035

Supplemental Content

Loading ...
Support Center